COCP · Cocrystal Pharma, Inc. · Investor Relations
$1.11
-0.04 (-3.06%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.96M
Shares
19.26M
Volume · Oct 5
41.3K
Avg daily vol (3M)
55.13K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-14 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-05-01 | International Society for Antiviral Research Conference (ICAR) 2026 | Conference |
Source: https://ir.cocrystalpharma.com/